Theravance Biopharma Inc (TBPH) earnings · $861.5M cap
These earnings events as JSON? API free 100/dayTheravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
This TBPH earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported TBPH revenue for 2026-06-30 was $20.7M. Net income was -$5.9M. Revenue was up 17.1% from 2026-03-31 to 2026-06-30. TBPH currently screens at market cap $861.5M.
When the next TBPH 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 17.1% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full TBPH research stays on the stock page; the tape stays on the quote page.
TBPH earnings FAQ
What are TBPH's latest revenue and net income?
Latest cached Theravance Biopharma Inc (TBPH) revenue for Jun 30, 2026 was $20.7M. Net income was -$5.9M. Statements: https://lician.com/financials/tbph
What is TBPH's latest diluted EPS?
Latest cached Theravance Biopharma Inc (TBPH) diluted EPS for Jun 30, 2026 was -$0.11.
What period does the latest TBPH earnings print cover?
The latest cached Theravance Biopharma Inc (TBPH) earnings print covers Jun 30, 2026. The prior cached period on this page is Mar 31, 2026.
How did TBPH revenue change from the prior cached period?
Cached Theravance Biopharma Inc (TBPH) revenue was up 17.1% from $17.7M (Mar 31, 2026) to $20.7M (Jun 30, 2026). Statements: https://lician.com/financials/tbph
Where are TBPH earnings listed?
Cached earnings facts for Theravance Biopharma Inc (TBPH) are listed at https://lician.com/earnings/tbph. Statements: https://lician.com/financials/tbph
Not investment advice.